Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease

Event Comm, Data Safety Monitoring Board, Steering Comm, D. H. Frank Gommans*, Joris Nas, Sara-Joan Pinto-Sietsma, Yvonne Koop, Regina E. Konst, Frans Mensink, Goaris W. A. Aarts, Lara S. F. Konijnenberg, Kimberley Cortenbach, Dominique V. M. Verhaert, Jos Thannhauser, Jan-Quinten Mol, Maxim J. P. Rooijakkers, Jacqueline L. Vos, Anouke van Rumund, Priya Vart, Robert-Jan HassingJan-Hein Cornel, C. Peter C. de Jager, Michel M. van den Heuvel, Hans G. van der Hoeven, Annelies Verbon, Yigal M. Pinto, Niels van Royen, Roland R. J. van Kimmenade, Peter W. de Leeuw, Michiel A. van Agtmael, Paul Bresser, Wiek H. van Gilst, Anton Vonk-Noordergraaf, Jan G. P. Tijssen

*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

10 Citaten (Scopus)
99 Downloads (Pure)

Vingerafdruk

Duik in de onderzoeksthema's van 'Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease'. Samen vormen ze een unieke vingerafdruk.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases